JNJ JOHNSON & JOHNSON
Price Chart
Executive Summary
Freedom Broker double-downgraded JNJ from Buy to Hold on October 22, 2025, while raising its price target from $180 to $190. The new target implies an 18.4% downside from the current price of $232.77, making it the second-lowest target on the Street (only the $155 low is lower). The consensus remains heavily bullish — 21 of 31 analysts rate JNJ Buy or Strong Buy, with a mean target of $252.87 (8.6% upside). Freedom Broker has a 66% accuracy rate on 68 calls and an average return of 11.8%, placing it in the middle of the pack. The downgrade is a sharp contrarian call against the bullish consensus and comes as EPS revisions have been essentially flat over the past 30 days. Institutional activity shows mixed signals: FMR added 39.7% and Norges Bank initiated a new $6.9B position, while Two Sigma cut 90.5% and Renaissance Technologies exited entirely. Short interest is elevated at 55.5% of off-exchange volume, suggesting bearish positioning. The next earnings report is due July 14, 2026, roughly nine months out, so no near-term catalyst is imminent. Bottom line: a high-conviction contrarian downgrade from a mid-tier firm, but the consensus and institutional inflows provide a strong counterweight.
Impact Score
Consensus & Targets
Consensus is heavily bullish: 7 Strong Buy, 14 Buy, 10 Hold, 0 Sell, 0 Strong Sell (31 analysts total). The consensus direction is strongly positive, with 67.7% of analysts at Buy or Strong Buy. Freedom Broker's Hold downgrade is a clear contrarian outlier.
Mean target is $252.87, median $260, high $285, low $155. Current price $232.77 implies 8.6% upside to the mean. Freedom Broker's $190 target is well below the mean and median, ranking as the second-lowest on the Street after the $155 low.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-13 | Leerink Partners | upgrade | Outperform | $265.00 |
| 2026-04-15 | Barclays | maintain | Equal-Weight | $255.00 |
| 2026-04-15 | Stifel | maintain | Hold | $250.00 |
| 2026-04-15 | Wells Fargo | maintain | Overweight | $263.00 |
| 2026-04-10 | Morgan Stanley | maintain | Overweight | $267.00 |
| 2026-03-30 | RBC Capital | reiterate | Outperform | $255.00 |
| 2026-03-19 | Barclays | maintain | Equal-Weight | $234.00 |
| 2026-03-17 | HSBC | maintain | Buy | $280.00 |
| 2026-03-11 | Citigroup | maintain | Buy | $274.00 |
| 2026-03-05 | JP Morgan | maintain | Neutral | $250.00 |
Over the past 30 days, there has been 1 upgrade (Leerink Partners from Market Perform to Outperform on May 13, 2026) and 0 downgrades. EPS revisions are essentially flat: the +1q estimate moved from $3.017 to $3.023 over 30 days, and the 0y estimate from $11.575 to $11.574. No strong revision trend.
Firm Track Record — Freedom Broker
Freedom Broker accuracy: 66% on 68 calls | avg return: 11.8%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 13 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Raymond James | 100% | 4/4 | 8.2% | top tier |
| Barclays | 100% | 4/4 | 12.4% | top tier |
| Goldman Sachs | 100% | 4/4 | 8.8% | top tier |
| UBS | 100% | 2/2 | 17.3% | top tier |
| Stifel | 100% | 2/2 | 11.2% | top tier |
| Morgan Stanley | 91% | 10/11 | 9.6% | top tier |
| B of A Securities | 89% | 8/9 | 9.3% | top tier |
| Citigroup | 83% | 5/6 | 10.3% | top tier |
| RBC Capital | 72% | 13/18 | 4.9% | top tier |
| Wells Fargo | 67% | 2/3 | 2.7% | top tier |
Freedom Broker has a 66% accuracy rate on 68 calls with an average return of 11.8%, placing it in the middle tier. Top-performing firms on JNJ include Raymond James, Barclays, Goldman Sachs, UBS, and Stifel (all 100% accuracy on limited calls). Morgan Stanley (91% on 11 calls) and B of A Securities (89% on 9 calls) are also strong. Leerink Partners (50% on 2 calls) and Cantor Fitzgerald (44% on 16 calls) are below average.
Earnings Estimates
Next earnings: Jul 14, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $3.02 | $2.96 — $3.21 | $25.2B | ↑0 ↓0 |
| 0y | $11.57 | $11.45 — $11.82 | $100.9B | ↑0 ↓0 |
| 0q | $2.85 | $2.65 — $3.00 | $25.0B | ↑0 ↓0 |
| +1y | $12.72 | $12.07 — $13.47 | $107.3B | ↑1 ↓0 |
Cross-Platform Signals
Insider trades: none reported. Congressional activity: one buy (Ro Khanna, $15K-$50K) and four small sells (Thomas Kean Jr, Rich McCormick x2, John Boozman, all $1K-$15K) — net neutral. Institutional changes: bullish signals from FMR (+39.7% to $3.9B) and Norges Bank (new $6.9B position); bearish from Two Sigma (-90.5%) and Renaissance Technologies (exit). Short interest is elevated at 55.5% of off-exchange volume, indicating bearish positioning. The analyst downgrade aligns with short interest and some institutional exits but diverges from the bullish consensus and large inflows from top holders.
Actionable Insight
The downgrade is a contrarian signal from a mid-tier firm, but the bullish consensus and large institutional inflows from FMR and Norges Bank provide strong support. Traders should treat this as a cautionary note rather than a sell signal — the elevated short interest and bearish institutional exits warrant monitoring, but the consensus remains firmly bullish.
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 6, 2026
3d ago
|
ANALYST-DOWNGRADE
| $192.41 $186.39 | ▲ +3.13% | ▲ +6.03% | $232.16 (−20.66%) |
|
May 31, 2026
9d ago
|
ANALYST-UPGRADE
| $227.67 $234.31 | ▲ +2.92% | ▲ +4.25% | $232.16 (+1.97%) |
|
May 20, 2026
21d ago
|
Court Ruling
| $229.12 $231.29 | ▲ +0.95% | ▼ −0.29% | $232.16 (+1.33%) |
|
May 13, 2026
27d ago
|
ANALYST-UPGRADE
| $230.79 $231.58 | ▲ +0.34% | ▲ +1.06% | $232.16 (+0.59%) |
|
May 7, 2026
4w ago
|
ANALYST-DOWNGRADE
| $192.41 $186.39 | ▲ +3.13% | ▲ +6.03% | $232.16 (−20.66%) |
|
May 5, 2026
5w ago
|
Court Ruling
| $225.50 $221.43 | ▼ −1.80% | ▼ −3.79% | $232.16 (+2.96%) |
|
Apr 14, 2026
8w ago
|
8-K
| $240.01 $225.97 | ▼ −5.85% | ▼ −7.24% | $232.16 (−3.27%) |
|
Mar 30, 2026
10w ago
|
Court Ruling
| $242.34 $238.33 | ▼ −1.65% | ▼ −5.96% | $232.16 (−4.20%) |
|
Mar 11, 2026
12w ago
|
DEFA14A
| $242.95 $237.20 | ▼ −2.37% | ▼ −0.18% | $232.16 (−4.44%) |
|
Feb 28, 2026
14w ago
|
Institutional Cluster
| $248.40 $242.34 | ▼ −2.44% | ▼ −1.23% | $232.16 (−6.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access